top of page
Modern Architecture

Venture Studio &
Corporate Advisory Services

Our services are designed to support life sciences companies, universities, and medical research institutes at every stage of their journey. From opportunity evaluation to post-transaction deal management, our comprehensive suite of services ensures that our clients are well-positioned for success. With a deep understanding of the life sciences sector, coupled with extensive experience in corporate advisory, we are uniquely positioned to guide our clients through the complexities of commercialisation, capital raising, and transaction execution. Whether you are a startup looking to become investor-ready, or an established company seeking to raise capital, our expert team is here to help.

Image by Fusion Medical Animation

Venture Studio

At D4 Bioventures, we understand the challenges faced by Australian universities, medical research institutes and public sector agencies involved in commercialising early-stage technologies.

We can help identify the most promising commercial opportunities in your portfolio, help founder teams develop their technological innovations into market-led, commercially viable business propositions, and then raise investment into these ventures.  Our investor network includes a range of alternative capital sources not typically accessible to technology commercialisation offices (e.g. family offices, HNWIs).

​

We also invest as principal in select projects, showcasing our belief in the projects we support.

Services

​

  • Opportunity Evaluation: Screening and prioritising commercialisation opportunities, identifying key next steps to become investor-ready, and advising on commercialization frameworks and incubation programs.
     

  • Venture Building – “Investor Readiness”: Validating market opportunities, sourcing management teams, developing business plans, connecting with industry partners, recommending transaction structuring options, and providing corporate governance advice.
     

  • Corporate Advisory and Capital Raising: Structuring deals, determining valuation and investment terms, identifying potential investors and/or partners, and advising on collateral material.
     

  • Transaction Execution: Executing transactions, negotiating terms, managing diligence and data rooms, and liaising with external consultants and legal counsel.
     

  • Post-transaction Deal Management: Monitoring and reviewing post-transaction activities and potential for ongoing Board or Advisory Board roles.

Corporate Advisory

For established companies in the Biotech, Medtech, Healthtech, or general life science areas, access to capital is a major block to growth.  At D4 Bioventures, we can connect you with multiple sources of private capital both domestically and internationally. In addition to capital raising, we offer high-level structuring advice, M&A and trade sales, management buy-outs, valuation, and other services.​

Our office is located in Sydney

Services

​

  • Corporate Advisory and Capital Raising: Structuring deals, determining valuation and investment terms, identifying potential investors and/or partners, and advising on collateral material.
     

  • Transaction Execution: Executing transactions, negotiating terms, managing diligence and data rooms, and liaising with external consultants and legal counsel.
     

  • Post-transaction Management: Monitoring and reviewing post-transaction activities and potential for ongoing Board or Advisory Board roles.

D4 Bioventures horizontal logo

SWG Capital Pty Ltd, (ABN 37 135 455 864) as a Corporate Authorised Representative (CAR No. 001296052) of FB Corp Pty Ltd, (ABN 16 675 876 490) (AFSL No. 557810)

The information in this website (the Information) has been prepared by SWG Capital. This information is for general information only and is not an offer for the purchase or sale of any financial product or services. The Information has been prepared for investors who qualify as wholesale clients under section 761G of the Corporations Act 2001 (Cth) (Corporations Act) or to any other person who is not required to be given a regulated disclosure document under the Corporations Act. The Information is not intended to provide you with financial or tax advice and does not take into account your objectives, financial situation or needs. Although we believe that the Information is correct, no warranty of accuracy, reliability or completeness is given, except for liability under statute which cannot be excluded. Please note that past performance may not be indicative of future performance and that no guarantee of performance, the return of capital or a particular rate of return is given the Licensee, SWG Capital or any other person. To the maximum extent possible, the Licensee, SWG Capital or any other person do not accept any liability for any statement in this Information.

© 2023 D4 Bioventures. All Rights Reserved.

bottom of page